Vascular Endothelial Growth Factor-directed Antibody Interactions

Vascular Endothelial Growth Factor Inhibitors

Vascular Endothelial Growth Factor Inhibitor

Carcinoma, Non-Small-Cell Lung

Uterine Cervical Neoplasms

Fallopian Tube Neoplasms

Glioblastoma

Kidney Neoplasms

Ovarian Neoplasms

Peritoneal Neoplasms

Colorectal Neoplasms

<section class="Section" data-sectioncode="34089-3"><a name="S11"></a><a name="section-9"></a><p></p><h1>11 DESCRIPTION</h1><p class="First">Bevacizumab is a vascular endothelial growth factor inhibitor. Bevacizumab is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab has an approximate molecular weight of 149 kDa. Bevacizumab is produced in a mammalian cell (Chinese Hamster Ovary) expression system.</p><p>Avastin (bevacizumab) injection is a sterile, preservative-free, clear to slightly opalescent, colorless to pale brown solution in a single-dose vial for intravenous use. Avastin contains bevacizumab at a concentration of 25 mg/mL in either a 100 mg/4 mL or 400 mg/16 mL single-dose vial.</p><p>Each mL of solution contains 25 mg bevacizumab, α,α-trehalose dihydrate (60 mg), polysorbate 20 (0.4 mg), sodium phosphate dibasic, anhydrous (1.2 mg), sodium phosphate monobasic, monohydrate (5.8 mg), and Water for Injection, USP. The pH is 6.2.</p></section>

Avastin

4 ML bevacizumab 25 MG/ML Injection

4 ML bevacizumab 25 MG/ML Injection [Avastin]

16 ML bevacizumab 25 MG/ML Injection

16 ML bevacizumab 25 MG/ML Injection [Avastin]

bevacizumab

Psoriasis (PsO)

Psoriatic Arthritis (PsA)

Ankylosing Spondylitis (AS)

Nonradiographic Axial Spondyloarthritis

Taltz

Juvenile Idiopathic Arthritis

Hidradenitis Suppurativa (HS)

Cosentyx

Siliq

Tremfya

Crohn's Disease (CD)

Ulcerative Colitis (UC)

Stelara

Skyrizi

Ilumya

Migraine

Cluster Headache

Migraine Prevention

Emgality

Qulipta

Acute Migraine

Ubrelvy

Nurtec ODT

Vyepti

Aimovig

Ajovy

Breast Cancer: HR+ (HER2-)

Verzenio

Ibrance

Kisqali

Atopic Dermatitis (Eczema)

Cibinqo

Eucrisa

Asthma (injectable)

Asthma OCS Dependent

Nasal Polyposis

Eosinophilic Esophagitis (EoE)

Prurigo Nodularis

Dupixent

Opzelura

Adbry

NSCLC ALK+ OR ROS1+ Disease

Lorbrena

Alecensa

Alunbrig

NSCLC cMET Mutation

Xalkori

Rheumatoid Arthritis (RA)

Xeljanz

Uveitis

Graft Versus Host Disease (GVHD)

Orencia

COVID-19 Treatment

Alopecia Areata

Olumiant

Multiple Sclerosis (MS)

Secondary Progressive Multiple Sclerosis

Zeposia

Rinvoq

Entyvio

Report Adverse Event 

Prescribing Information 

Submit MSL Request 

Formulary Information 

Reimbursement Information 

Coverage Authorization Request 

Coverage Authorization Appeals 

Letter of Medical Necessity 

Avastin Prescriber Service & Patient Consent Form 

Genentech Patient Foundation Application Form (1/2)

Genentech Patient Foundation Application Form (2/2) - Patient Consent Form 

Enroll in Patient Savings Program 

About Avastin 

Patient Resources 

About Avastin: Metastatic Colorectal Cancer (mCRC)

Side Effects: Metastatic Colorectal Cancer (mCRC)

Receiving Avastin: Metastatic Colorectal Cancer (mCRC)

Instructions For Use: Metastatic Colorectal Cancer (mCRC)

About Avastin: Non–Small Cell Lung Cancer (NSCLC)

Side Effects: Non–Small Cell Lung Cancer (NSCLC)

Receiving Avastin: Non–Small Cell Lung Cancer (NSCLC)

Instructions For Use: Non–Small Cell Lung Cancer (NSCLC)

About Avastin: Metastatic Kidney Cancer (mRCC)

Side Effects: Metastatic Kidney Cancer (mRCC)

Receiving Avastin: Metastatic Kidney Cancer (mRCC)

Instructions For Use: Metastatic Kidney Cancer (mRCC)

About Avastin: Advanced Cervical Cancer (CC)

Side Effects: Advanced Cervical Cancer (CC)

Receiving Avastin: Advanced Cervical Cancer (CC)

Instructions For Use: Advanced Cervical Cancer (CC)

About Avastin: Ovarian Cancer (OC)

Side Effects: Ovarian Cancer (OC)

Receiving Avastin: Ovarian Cancer (OC)

Instructions For Use: Ovarian Cancer (OC)

About Avastin: Recurrent Glioblastoma (GBM)

Side Effects: Recurrent Glioblastoma (GBM)

Receiving Avastin: Recurrent Glioblastoma (GBM)

Instructions For Use: Recurrent Glioblastoma (GBM)

Pharmacy List

Avastin Prescriber Service Form - Online Portal 

Billing & Coding Guide:  Metastatic Colorectal Cancer (mCRC)

Billing & Coding Guide: Non–Small Cell Lung Cancer (NSCLC)

Billing & Coding Guide: Metastatic Kidney Cancer (mRCC)

Billing & Coding Guide: Recurrent Glioblastoma (GBM)

Billing & Coding Guide: Ovarian Cancer (OC) 

Billing & Coding Guide: Hepatocellular Cancer (HCC)

Patient Consent Form 

My Patient Solutions - HCP Portal (for managing service requests)

Patient Consent Form - Spanish